Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
series A
Biotech
DNA med-focused biotech Seawolf surfaces with $1.2B Sanofi pact
Gene therapy biotech Seawolf has emerged from the deep with $100 million to fuel its DNA therapeutic ambitions and a billion-dollar deal with Sanofi.
Michael Gibney
Nov 16, 2026 5:00am
Jazz's Actio buyout gives rise to Setara with $90M series A
Oct 30, 2026 6:30am
Estuary emerges with $103M for kidney disease gene therapies
Oct 16, 2026 6:30am
ai3Bio buzzing with $48M for STING pathway targeting pipeline
Sep 29, 2026 9:00am
Schrödinger births new immunology focused biotech, Tectora
Sep 9, 2026 7:00am
Solstice rises with $225M series A for next-gen CTLA-4 therapy
Sep 9, 2026 7:00am